Vieworks (KOSDAQ:A100120) - Share price, News & Analysis

A100120 fundamental analysis
Snowflake Score
Valuation	5/6
Future Growth	1/6
Past Performance	5/6
Financial Health	5/6
Dividends	3/6

A100120 Stock Overview

Vieworks Co., Ltd. develops, manufactures, and sells imaging systems and solutions.

Rewards

Trading at 66.2% below our estimate of its fair value

Earnings are forecast to grow 7.52% per year

Earnings grew by 46.2% over the past year

Risk Analysis

Unstable dividend track record

Vieworks Competitors

Canon

TSE:7751

JP¥3.3t

PerkinElmer

NYSE:PKI

US$18.5b

iRay Technology

SHSE:688301

CN¥27.9b

Varex Imaging

NasdaqGS:VREX

US$876.5m

Price History & Performance

Summary of all time highs, changes and price drops for Vieworks
Historical stock prices
Current Share Price	₩40,650.00
52 Week High	₩46,650.00
52 Week Low	₩34,700.00
Beta	0.52
1 Month Change	-0.37%
3 Month Change	5.18%
1 Year Change	9.42%
3 Year Change	29.67%
5 Year Change	-27.41%
Change since IPO	194.57%

Shareholder Returns

	A100120	KR Medical Equipment	KR Market
7D	4.2%	-0.04%	1.6%
1Y	9.4%	-5.8%	-14.2%

Return vs Industry: A100120 exceeded the KR Medical Equipment industry which returned -5.8% over the past year.

Return vs Market: A100120 exceeded the KR Market which returned -14.2% over the past year.

Price Volatility

Is A100120's price volatile compared to industry and market?
A100120 volatility
A100120 Average Weekly Movement	4.4%
Medical Equipment Industry Average Movement	5.8%
Market Average Movement	5.5%
10% most volatile stocks in KR Market	10.4%
10% least volatile stocks in KR Market	3.2%

Stable Share Price: A100120 is not significantly more volatile than the rest of KR stocks over the past 3 months, typically moving +/- 4% a week.

Volatility Over Time: A100120's weekly volatility (4%) has been stable over the past year.

About the Company

Founded	Employees	CEO	Website
1999	332	Hooshik Kim	https://www.vieworks.com

Vieworks Co., Ltd. develops, manufactures, and sells imaging systems and solutions. The company offers X-ray detectors and image processing technologies for general radiography system, dental and surgical C-arm systems, radiography and fluoroscopy system, veterinary radiography system, industrial inspection instrument, and other applications. It also provides industrial cameras; and bio imaging systems comprising in vivo imaging systems under the VISQUE brand.

Vieworks Fundamentals Summary

How do Vieworks's earnings and revenue compare to its market cap?
A100120 fundamental statistics
Market Cap	₩373.24b
Earnings (TTM)	₩33.47b
Revenue (TTM)	₩193.14b

11.2x

P/E Ratio

1.9x

P/S Ratio

Is A100120 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report
A100120 income statement (TTM)
Revenue	₩193.14b
Cost of Revenue	₩97.74b
Gross Profit	₩95.40b
Other Expenses	₩61.93b
Earnings	₩33.47b

Last Reported Earnings

Dec 31, 2021

Next Earnings Date

n/a

Earnings per share (EPS)	3.65k
Gross Margin	49.40%
Net Profit Margin	17.33%
Debt/Equity Ratio	11.2%

How did A100120 perform over the long term?

See historical performance and comparison

Dividends

1.8%

Current Dividend Yield

21%

Payout Ratio

Valuation

Is Vieworks undervalued compared to its fair value and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

Below Fair Value
Significantly Below Fair Value
PE vs Industry
PE vs Market
PEG Ratio
PB vs Industry

>50%

Undervalued compared to fair value

Share Price vs. Fair Value

Below Fair Value: A100120 (₩40650) is trading below our estimate of fair value (₩120373.46)

Significantly Below Fair Value: A100120 is trading below fair value by more than 20%.

Price To Earnings Ratio

PE vs Industry: A100120 is good value based on its PE Ratio (11.2x) compared to the KR Medical Equipment industry average (13.5x).

PE vs Market: A100120 is good value based on its PE Ratio (11.2x) compared to the KR market (14.1x).

Price to Earnings Growth Ratio

PEG Ratio: A100120 is poor value based on its PEG Ratio (1.5x)

Price to Book Ratio

PB vs Industry: A100120 is good value based on its PB Ratio (2x) compared to the KR Medical Equipment industry average (2.4x).

Future Growth

How is Vieworks forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?

Future Growth Score

1/6

Future Growth Score 1/6

Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Future ROE

7.5%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts

Analyst Future Growth Forecasts

Earnings vs Savings Rate: A100120's forecast earnings growth (7.5% per year) is above the savings rate (3.5%).

Earnings vs Market: A100120's earnings (7.5% per year) are forecast to grow slower than the KR market (14.9% per year).

High Growth Earnings: A100120's earnings are forecast to grow, but not significantly.

Revenue vs Market: A100120's revenue (9.6% per year) is forecast to grow slower than the KR market (9.8% per year).

High Growth Revenue: A100120's revenue (9.6% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: A100120's Return on Equity is forecast to be low in 3 years time (15.9%).

Past Performance

How has Vieworks performed over the past 5 years?

Past Performance Score

5/6

Past Performance Score 5/6

Quality Earnings
Growing Profit Margin
Earnings Trend
Accelerating Growth
Earnings vs Industry
High ROE

2.7%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: A100120 has high quality earnings.

Growing Profit Margin: A100120's current net profit margins (17.3%) are higher than last year (14.3%).

Past Earnings Growth Analysis

Earnings Trend: A100120's earnings have grown by 2.7% per year over the past 5 years.

Accelerating Growth: A100120's earnings growth over the past year (46.2%) exceeds its 5-year average (2.7% per year).

Earnings vs Industry: A100120 earnings growth over the past year (46.2%) exceeded the Medical Equipment industry 17.9%.

Return on Equity

High ROE: A100120's Return on Equity (17.8%) is considered low.

Financial Health

How is Vieworks's financial position?

Financial Health Score

5/6

Financial Health Score 5/6

Short Term Liabilities
Long Term Liabilities
Debt Level
Reducing Debt
Debt Coverage
Interest Coverage

Financial Position Analysis

Short Term Liabilities: A100120's short term assets (₩156.7B) exceed its short term liabilities (₩49.6B).

Long Term Liabilities: A100120's short term assets (₩156.7B) exceed its long term liabilities (₩3.0B).

Debt to Equity History and Analysis

Debt Level: A100120 has more cash than its total debt.

Reducing Debt: A100120's debt to equity ratio has increased from 1.6% to 11.2% over the past 5 years.

Debt Coverage: A100120's debt is well covered by operating cash flow (76.8%).

Interest Coverage: A100120's interest payments on its debt are well covered by EBIT (119.9x coverage).

Balance Sheet

Dividend

What is Vieworks's current dividend yield, its reliability and sustainability?

Dividend Score

3/6

Dividend Score 3/6

Notable Dividend
High Dividend
Stable Dividend
Growing Dividend
Earnings Coverage
Future Dividend Coverage

1.85%

Current Dividend Yield

Dividend Yield vs Market

Notable Dividend: A100120's dividend (1.85%) is higher than the bottom 25% of dividend payers in the KR market (0.85%).

High Dividend: A100120's dividend (1.85%) is low compared to the top 25% of dividend payers in the KR market (2.75%).

Stability and Growth of Payments

Stable Dividend: Whilst dividend payments have been stable, A100120 has been paying a dividend for less than 10 years.

Growing Dividend: A100120's dividend payments have increased, but the company has only paid a dividend for 3 years.

Earnings Payout to Shareholders

Earnings Coverage: With its low payout ratio (21%), A100120's dividend payments are well covered by earnings.

Cash Payout to Shareholders

Cash Flow Coverage: With its reasonable cash payout ratio (69.1%), A100120's dividend payments are covered by cash flows.

Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?

CEO

Hooshik Kim (57 yo)

no data

Tenure

Mr. Hooshik Kim has been the Chief Executive Officer and Director of Vieworks Co. Ltd since February 2003. Mr. Kim served as Senior Research Engineer of Samsung Aerospace Industries from January 1990 to Ap...

Ownership

Who are the major shareholders and have insiders been buying or selling?

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Data	Last Updated (UTC time)
Company Analysis	2022/05/22 00:00
End of Day Share Price	2022/05/20 00:00
Earnings	2021/12/31
Annual Earnings	2021/12/31